Related references
Note: Only part of the references are listed.The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth inKRAS-Driven Lung Cancer
Seon-Hyeong Lee et al.
CANCERS (2020)
Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation
Jae-Seon Lee et al.
EBIOMEDICINE (2019)
Autophagy Keeps the Balance in Tissue Homeostasis
Michael Buszczak et al.
DEVELOPMENTAL CELL (2019)
Autophagy: A novel mechanism of chemoresistance in cancers
Xinyu Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
A view on drug resistance in cancer
Neil Vasan et al.
NATURE (2019)
Gastric cancer depends on aldehyde dehydrogenase 3A1 for fatty acid oxidation
Jae-Seon Lee et al.
SCIENTIFIC REPORTS (2019)
Targeting cancer energy metabolism: a potential systemic cure for cancer
Soo-Youl Kim
ARCHIVES OF PHARMACAL RESEARCH (2019)
Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer
Cally J. Ho et al.
CANCERS (2019)
Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres
Junseong Park et al.
NEURO-ONCOLOGY (2018)
Cancer Energy Metabolism: Shutting Power off Cancer Factory
Soo-Youl Kim
BIOMOLECULES & THERAPEUTICS (2018)
Targeting Mitochondrial Oxidative Phosphorylation Abrogated Irinotecan Resistance in NSCLC
Soohyun Lee et al.
SCIENTIFIC REPORTS (2018)
mTORC1 as the main gateway to autophagy
Yoana Rabanal-Ruiz et al.
SIGNALLING MECHANISMS IN AUTOPHAGY (2017)
Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion
Joon Hee Kang et al.
ONCOTARGET (2016)
Aldehyde dehydrogenase is used by cancer cells for energy metabolism
Joon Hee Kang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Selective Inhibition of Deactivated Mitochondrial Complex I by Biguanides
Satoshi Matsuzaki et al.
BIOCHEMISTRY (2015)
Drug resistance to targeted therapies: Deja vu all over again
Floris H. Groenendijk et al.
MOLECULAR ONCOLOGY (2014)
Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
Martin P. Barr et al.
PLOS ONE (2013)
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
X. Sui et al.
CELL DEATH & DISEASE (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application
Vindhya Koppaka et al.
PHARMACOLOGICAL REVIEWS (2012)
Autophagy is a therapeutic target in anticancer drug resistance
Suning Chen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2010)
Termination of autophagy and reformation of lysosomes regulated by mTOR
Li Yu et al.
NATURE (2010)
Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology
Lee M. Ellis et al.
CLINICAL CANCER RESEARCH (2009)
Mammalian TOR: A homeostatic ATP sensor
PB Dennis et al.
SCIENCE (2001)
Share Paper
